Jeffrey E. Russel

Array ( [id] => 7434442 [patent_doc_number] => 20040162415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Novel peptides and remedy for bone diseases containing the same as active ingredient' [patent_app_type] => new [patent_app_number] => 10/096525 [patent_app_country] => US [patent_app_date] => 2002-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2236 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162415.pdf [firstpage_image] =>[orig_patent_app_number] => 10096525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536363 [patent_doc_number] => 20020193311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Novel cytostatic conjugates with integrin ligands' [patent_app_type] => new [patent_app_number] => 10/096120 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20493 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193311.pdf [firstpage_image] =>[orig_patent_app_number] => 10096120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1196926 [patent_doc_number] => 06727227 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-27 [patent_title] => 'Tetrapetide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application' [patent_app_type] => B1 [patent_app_number] => 09/959852 [patent_app_country] => US [patent_app_date] => 2002-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10731 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727227.pdf [firstpage_image] =>[orig_patent_app_number] => 09959852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535786 [patent_doc_number] => 20020193285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Neuroprotectants formulations and methods' [patent_app_type] => new [patent_app_number] => 10/090441 [patent_app_country] => US [patent_app_date] => 2002-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6516 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193285.pdf [firstpage_image] =>[orig_patent_app_number] => 10090441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 472655 [patent_doc_number] => 07229961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Compositions and methods for enhancing drug delivery across and into ocular tissues' [patent_app_type] => utility [patent_app_number] => 10/083960 [patent_app_country] => US [patent_app_date] => 2002-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 47 [patent_no_of_words] => 27602 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/229/07229961.pdf [firstpage_image] =>[orig_patent_app_number] => 10083960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923036 [patent_doc_number] => 20020115616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Novel inhibitor of beta amyloid cleavage enzyme' [patent_app_type] => new [patent_app_number] => 10/075686 [patent_app_country] => US [patent_app_date] => 2002-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4756 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115616.pdf [firstpage_image] =>[orig_patent_app_number] => 10075686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651192 [patent_doc_number] => 20030105026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof' [patent_app_type] => new [patent_app_number] => 10/072815 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30588 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105026.pdf [firstpage_image] =>[orig_patent_app_number] => 10072815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059603 [patent_doc_number] => 06852693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-08 [patent_title] => 'Compositions and methods for promoting lipid mobilization in humans' [patent_app_type] => utility [patent_app_number] => 10/072419 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13864 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852693.pdf [firstpage_image] =>[orig_patent_app_number] => 10072419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 930941 [patent_doc_number] => 06979445 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-27 [patent_title] => 'Method for treating von willebrand\'s disease' [patent_app_type] => utility [patent_app_number] => 10/468113 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1700 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979445.pdf [firstpage_image] =>[orig_patent_app_number] => 10468113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6474893 [patent_doc_number] => 20020151592 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2002-10-17 [patent_title] => ' ENHANCEMENT OF VASCULAR FUNCTION BY MODULATION OF ENDOGENOUS NITRIC OXIDE PRODUCTION OR ACTIVITY\n ' [patent_app_type] => republication-amended [patent_app_number] => 10/060252 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14084 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0151/20020151592.pdf [firstpage_image] =>[orig_patent_app_number] => 10060252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6474893 [patent_doc_number] => 20020151592 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2002-10-17 [patent_title] => ' ENHANCEMENT OF VASCULAR FUNCTION BY MODULATION OF ENDOGENOUS NITRIC OXIDE PRODUCTION OR ACTIVITY\n ' [patent_app_type] => republication-amended [patent_app_number] => 10/060252 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14084 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0151/20020151592.pdf [firstpage_image] =>[orig_patent_app_number] => 10060252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658504 [patent_doc_number] => 20030078369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Apicidin-derived cyclic tetrapeptides' [patent_app_type] => new [patent_app_number] => 10/066451 [patent_app_country] => US [patent_app_date] => 2002-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47079 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078369.pdf [firstpage_image] =>[orig_patent_app_number] => 10066451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 941366 [patent_doc_number] => 06969757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-29 [patent_title] => 'Differential labeling for quantitative analysis of complex protein mixtures' [patent_app_type] => utility [patent_app_number] => 10/057789 [patent_app_country] => US [patent_app_date] => 2002-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 23255 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/969/06969757.pdf [firstpage_image] =>[orig_patent_app_number] => 10057789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6548502 [patent_doc_number] => 20020137902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Method for producing crystal polymorphs and crystal polymorphs produced thereby' [patent_app_type] => new [patent_app_number] => 10/056490 [patent_app_country] => US [patent_app_date] => 2002-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5836 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137902.pdf [firstpage_image] =>[orig_patent_app_number] => 10056490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 589820 [patent_doc_number] => 07435716 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia' [patent_app_type] => utility [patent_app_number] => 10/451795 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 12112 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435716.pdf [firstpage_image] =>[orig_patent_app_number] => 10451795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016860 [patent_doc_number] => 20020103126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Stable pharmaceutical form of administration for peptides, proteins and nucleic acids' [patent_app_type] => new [patent_app_number] => 10/046311 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5917 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103126.pdf [firstpage_image] =>[orig_patent_app_number] => 10046311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 680002 [patent_doc_number] => 07084117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof' [patent_app_type] => utility [patent_app_number] => 10/466152 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 6218 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084117.pdf [firstpage_image] =>[orig_patent_app_number] => 10466152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1125509 [patent_doc_number] => 06790438 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-14 [patent_title] => 'Cross-linked collagenic peptide for preventing post-surgical adhesions' [patent_app_type] => B1 [patent_app_number] => 09/914424 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10548 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790438.pdf [firstpage_image] =>[orig_patent_app_number] => 09914424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625339 [patent_doc_number] => 06723830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-20 [patent_title] => 'Short peptides which selectively modulate the activity of protein kinases' [patent_app_type] => B2 [patent_app_number] => 10/038612 [patent_app_country] => US [patent_app_date] => 2002-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21683 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723830.pdf [firstpage_image] =>[orig_patent_app_number] => 10038612 [rel_patent_id] =>[rel_patent_doc_number] =>)